Influence of imatinib interruption and rechallenge on the residual disease in patients with advanced GIST: results of the BFR14 prospective French Sarcoma Group randomised, phase III trial.
| Autor: | Patrikidou, A.1, Chabaud, S.2, Ray-Coquard, I.2, Bui, B. N.3, Adenis, A.4, Rios, M.5, Bertucci, F.6, Duffaud, F.7, Chevreau, C.8, Cupissol, D.9, Domont, J.1, Pérol, D.2, Blay, J. Y.10, Le Cesne, A.1 |
|---|---|
| Zdroj: | Annals of Oncology. Apr2013, Vol. 24 Issue 4, p1087-1093. 7p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|